Detalhe da pesquisa
1.
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer.
Cancer
; 130(11): 1916-1929, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529566
2.
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin
; 67(3): 245-253, 2017 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222223
3.
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
Cancer
; 129(5): 685-696, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579470
4.
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet
; 399(10338): 1886-1901, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569466
5.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051385
6.
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
J Urol
; 207(3): 581-591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694160
7.
Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations.
J Urol
; 208(2): 301-308, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377775
8.
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.
Lancet Oncol
; 22(3): 402-410, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662287
9.
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
Oncology (Williston Park)
; 35(3): 119-125, 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818052
10.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med
; 376(5): 417-428, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146658
11.
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.
J Urol
; 203(1): 115-119, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502940
12.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
J Urol
; 201(3): 528-534, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759696
13.
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1504-1515, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316827
14.
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply.
Lancet
; 400(10356): 885-886, 2022 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116477
15.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
J Urol
; 199(3): 683-690, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203269
16.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
J Urol
; 199(4): 990-997, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331546
17.
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH.
Prostate
; 77(16): 1592-1600, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28994485
18.
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database.
Prostate
; 77(2): 154-163, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683213
19.
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
Cancer
; 123(13): 2489-2496, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323339
20.
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.
J Urol
; 197(2): 376-384, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27593476